论文部分内容阅读
目的:观察老年糖尿病足患者给予黄芪桂枝汤联合西药治疗的临床疗效。方法:从我院于2013年11月~2016年11月就诊老年糖尿病足患者30例,随机分为2组,常规组15例常规给予弥可保片治疗,研究组15例给予黄芪桂枝汤联合弥可保片治疗,对比两组患者治疗后FPG、2hPG、HbA1c、血流变、中医全身与足部证候评分、足部中医证候疗效。结果:治疗后研究组FPG、2hPG、HbA1c指标改善情况显著优于常规组,差异有统计学意义(P<0.05);研究组血流变各项指标明显低于常规组,差异有统计学意义(P<0.05);研究组患足及全身证候评分明显比常规组低,差异有统计学意义(P<0.05);研究组足部证候总有效为80.00%显著高于常规组率33.33%,差异有统计学意义(P<0.05)。结论:老年糖尿病足患者给予黄芪桂枝汤联合西药治疗可有效提高治疗疗效,有效改善患者血液循环与病症。
Objective: To observe the clinical efficacy of Huangqi Guizhi Decoction combined with western medicine in elderly patients with diabetic foot. Methods: Thirty patients with senile diabetic foot from November 2013 to November 2016 in our hospital were randomly divided into two groups. Fifteen patients in the conventional group were treated with Mi Kebao tablets. Fifteen patients in the study group were treated with Huangqi Guizhi Decoction Combined with Mi can protect film treatment, compared two groups of patients after treatment FPG, 2hPG, HbA1c, blood rheology, TCM body and foot syndrome score, foot TCM syndrome curative effect. Results: After treatment, the improvement of FPG, 2hPG and HbA1c in the study group was significantly better than that in the conventional group (P <0.05). The indexes of hemorrheology in the study group were significantly lower than those in the conventional group (P <0.05). The scores of foot and systemic syndrome in study group were significantly lower than those in normal group (P <0.05). The total effective rate of foot syndrome in study group was 80.00%, significantly higher than that of routine group (33.33) %, The difference was statistically significant (P <0.05). Conclusion: The elderly diabetic foot patients given astragalus Guizhi Decoction combined with western medicine can effectively improve the therapeutic effect, effectively improve the patient’s blood circulation and illness.